LongTermInvestr

LongTermInvestr | Joined since 2024-03-01

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

2

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
2
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2 months ago | Report Abuse

Williamh, can you elaborate how cannabis for medicine can add value? In my opinion, the use of cannabis for medicine most likely could not cover its shrinking core business due to smaller market.

Stock

2 months ago | Report Abuse

I know it's difficult to see the direction of this stock trend is going towards. However, could this be the potential reasons for trend reversal?

"Meanwhile, sales generated from its vape brand, Vuse, stood at less than two per cent of the BAT sales, with the group targeting the new category (Vuse and THP) to achieve 30 per cent of total sales in the next three to five years."

"Currently, Vuse products are available in 6,600 retail outlets and 1,100 vape stores, significantly fewer than the 45,000 outlets for BAT's combustible cigarettes, suggesting more room to grow," it added.

Source: https://www.klsescreener.com/v2/news/view/1278081/challenging-outlook-for-bat-due-to-inconsistent-revenue-sources